NCT01617369View on ClinicalTrials.gov

Study to Characterize the Durability of Hypertonic Saline to Enhance Mucociliary Clearance in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy Subjects
Interventions
DEVICE

Hypertonic Saline

2.8% NaCl x 4ml via nebulizer

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT01617369 - Study to Characterize the Durability of Hypertonic Saline to Enhance Mucociliary Clearance in Healthy Subjects | Biotech Hunter | Biotech Hunter